EXEL
62.23-0.60 -0.96%Past year
Loading chart…
Loading financials…
Company snapshot
- Ticker
- EXEL
- Exchange
- NMS
- Sector
- Healthcare
- Industry
- Biotechnology
- Market cap
- $15.58B
- Employees
- 1,077
- Currency
- USD
- Website
- https://www.exelixis.com
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are…
Latest coverage
- 2 Under-the-Radar Stocks to Buy and Hold
October 16, 2026
Related Other stocks
UnitedHealth Group IncorporatedUNH
J.B. Hunt Transport Services, Inc.JBHT
Zillow Group, Inc.ZG
Opendoor Technologies Inc.OPEN